20/20 Biolabs Inc.

Contributing Author

Recent Articles by 20/20 Biolabs Inc.

Jul-09	20/20 BioLabs Highlights Investor Webinar Focused on OneTest for Medicare, Serial Biomarker Tracking, and Strong Q2 Revenue Growth AIDX GlobeNewswire
Jun-22	20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month AIDX -6.85% GlobeNewswire
May-27	20/20 Biolabs' Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters AIDX GlobeNewswire
May-22	20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand AIDX -18.67% GlobeNewswire
May-20	20/20 BioLabs Reports First Quarter 2026 Financial Results and Recent Operational Progress AIDX AIDX -6.59% GlobeNewswire
May-14	20/20 BioLabs to Attend Sidoti Micro-Cap Virtual Conference on May 20, 2026 AIDX GlobeNewswire
May-12	20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina AIDX +6.33% GlobeNewswire
Apr-07	20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest for Cancer Through Evexia Platform AIDX -5.45% GlobeNewswire
Mar-31	20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational Progress AIDX +5.62% GlobeNewswire
Mar-27	Maryland Fire Departments Awarded $520,000 for Cancer Screenings using 20/20 BioLabs' OneTest Multi-Cancer Early Detection Blood Test AIDX GlobeNewswire
Mar-24	20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare to Integrate Advanced CKD Prediction Technology into Its Longevity Test Program AIDX -17.59% GlobeNewswire
Mar-12	20/20 BioLabs Highlights Advantages of its Patented Protein Biomarker Technology for Multi-Cancer Early Detection in Light of Recent Studies AIDX -8.49% GlobeNewswire
Feb-25	20/20 BioLabs Launches OneTest for Longevity Blood Test and Chronic Disease Risk Assessment and Management Solution Built with IBM AI Capabilities AIDX -28.82% GlobeNewswire
Feb-20	20/20 BioLabs to Host Virtual Investor Webinar on Thursday, February 26, 2026 at 2:00 p.m. Eastern Time AIDX -38.04% GlobeNewswire
Feb-19	20/20 BioLabs Debuts Trading on Nasdaq Under Ticker Symbol "AIDX" Following 3 Consecutive Years of Sales Growth AIDX GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)